Molecular Imaging: Page 441

MRI and FDG-PET/CT recommended for advanced breast cancer

By Cynthia E. Keen

FDG-PET/CT should be used in conjunction with breast MRI as a complementary imaging tool for patients with locally advanced breast cancer, because the hybrid imaging modality can detect distant metastases outside the field-of-view of breast MRI, according to researchers from Stanford University in California.

April 3, 2008

Philips wins long-term Chinese research contract

By AuntMinnie.com staff writers

Royal Philips Electronics, the parent company of Philips Healthcare of Andover, MA, has entered into a long-term research collaboration with West China Hospital in Chengdu, China, the company said.

April 2, 2008

Naviscan signs M. D. Anderson

By AuntMinnie.com staff writers

PET developer Naviscan PET Systems has added the University of Texas M. D. Anderson Cancer Center in Houston to its client list.

April 2, 2008

Cardinal to sell UltraSPECT packages

By AuntMinnie.com staff writers

Healthcare products firm Cardinal Health has inked an exclusive agreement with nuclear medicine vendor UltraSPECT of Merrick, NY.

April 1, 2008

CTA less costly than SPECT for suspected heart disease

By AuntMinnie.com staff writers

A multicenter clinical trial presented today at the American College of Cardiology (ACC) meeting in Chicago has found that 64-slice coronary CT angiography (CTA) is less costly than SPECT myocardial perfusion imaging in patients without a prior diagnosis of coronary artery disease (CAD).

March 31, 2008

ART revenues slide in 2007

By AuntMinnie.com staff writers

Medical device firm ART Advanced Research Technologies' transition to a direct distribution sales model adversely affected revenues at the Montreal-based company in 2007.

March 30, 2008

International Isotopes revenues, net loss grow

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes saw its revenues and net loss increase in 2007.

March 27, 2008

PET shows superiority in detecting coronary artery disease

By Wayne Forrest

PET demonstrates excellent diagnostic capabilities in detecting coronary artery disease, and is superior to perfusion imaging, CT angiography (CTA), and MR angiography (MRA), according to a retrospective review of PET research studies over a 30-year period.

March 27, 2008

Lantheus focuses on cardiac imaging following BMS spinoff

By Wayne Forrest

Divested by parent company Bristol-Myers Squibb (BMS) in January, Lantheus Medical Imaging is focusing its corporate strategy on opportunities in cardiac imaging following the division's spinoff. For the immediate future, the North Billerica, MA, company plans to continue its manufacture and marketing of radiopharmaceutical and ultrasound contrast products. Heading the Lantheus effort is president and CEO Don Kiepert, who spoke with AuntMinnie.com about the company's strategic plans.

March 26, 2008

FluoroPharma licenses MGH PET agents

By AuntMinnie.com staff writers

Imaging agent developer FluoroPharma of Boston has signed an agreement with Massachusetts General Hospital (MGH), also of Boston, for the development and commercialization of PET agents for diagnosing Alzheimer's disease and monitoring treatment.

March 26, 2008

Siemens launches PETNet in India

By AuntMinnie.com staff writers

Siemens Healthcare of Erlangen, Germany, has opened its first PETNet Solutions radiopharmaceutical production facility in India.

March 25, 2008

NOPR study: PET influences cancer care

By AuntMinnie.com staff writers

The imaging results from FDG-PET scans change clinicians' decisions in the treatment and care for more than one in three cancer patients, according to data collected by the U.S. National Oncologic PET Registry (NOPR) and published online in the Journal of Clinical Oncology.

March 24, 2008

Previous Page

Page 441 of 615

Next Page